Reviva Pharmaceuticals (RVPH) plans a public offering of shares and warrants, using the proceeds to fund research and development, support working capital, and cover general corporate purposes.

The transaction is subject to market conditions, and "there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms," the company said late Thursday in a statement.